Group 1 - The medical beauty sector increased by 1.68% on November 11, with Ai Meike leading the gains [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] - Major stocks in the medical beauty sector showed varied performance, with Ai Meike closing at 160.97, up 2.86%, and Jinbo Biological down 2.00% at 231.20 [1] Group 2 - The net inflow of main funds in the medical beauty sector was 104 million yuan, while retail investors experienced a net outflow of 68.75 million yuan [1] - Specific stock fund flows indicated that Ai Meike had a net outflow of 500.88 million yuan, while Huaxi Biological saw a net inflow of 276.77 million yuan [2] - ST Meigu experienced a significant net outflow of 1.79 million yuan, reflecting a decline of 18.27% [2]

Group 1 - The medical beauty sector increased by 4.29% on November 10, with *ST Meigu leading the gains [1] - The Shanghai Composite Index closed at 4018.6, up 0.53%, while the Shenzhen Component Index closed at 13427.61, up 0.18% [1] - The main funds in the medical beauty sector saw a net inflow of 94.61 million yuan, while retail funds experienced a net outflow of 53.71 million yuan [1] Group 2 - *ST Meigu's closing price was 4.22 yuan, with a rise of 4.98% and a trading volume of 163,200 shares, amounting to a transaction value of 68.05 million yuan [1] - Aimeike's closing price was 156.50 yuan, with a rise of 4.92% and a trading volume of 110,400 shares, amounting to a transaction value of 173.27 million yuan [1] - Huaxi Biological's closing price was 51.46 yuan, with a rise of 3.37% and a trading volume of 40,500 shares, amounting to a transaction value of 207 million yuan [1]

Market Overview - The medical beauty sector experienced a decline of 0.93% on November 7, with Ai Meike leading the drop [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - The closing prices and performance of key stocks in the medical beauty sector are as follows: - *ST Meigu: Closed at 4.02, up 1.77% with a trading volume of 143,600 shares and a turnover of 57.01 million yuan [1] - Jinbo Biological: Closed at 234.00, up 0.02% with a trading volume of 7,738.5 shares and a turnover of 1.83 billion yuan [1] - Huaxi Biological: Closed at 49.78, down 0.04% with a trading volume of 17,300 shares and a turnover of 86.15 million yuan [1] - Ai Meike: Closed at 149.16, down 1.87% with a trading volume of 30,900 shares and a turnover of 465 million yuan [1] Capital Flow - The medical beauty sector saw a net outflow of 46.6453 million yuan from main funds, while retail investors contributed a net inflow of 34.3979 million yuan [1] - The capital flow for key stocks is as follows: - *ST Meigu: Net outflow of 2.6832 million yuan, down 4.71% [2] - Huaxi Biological: Net outflow of 3.3342 million yuan, down 3.87% [2] - Ai Meike: Net outflow of 40.6279 million yuan, down 8.74% [2]

证券代码：000615 证券简称：*ST美谷 公告编号：2025-092 奥园美谷科技股份有限公司 关于对襄阳隆运减资的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、对外投资情况概述 奥园美谷科技股份有限公司（以下简称"公司"）分别于 2016 年 9 月 7 日 和 2016 年 9 月 26 日召开的第八届董事会第十六次会议和 2016 年第四次临时股 东大会，审议通过了《关于对外投资设立产业基金暨关联交易的议案》，公司与 京汉控股集团有限公司、北京隆运私募基金管理有限公司等共同发起设立襄阳隆 运股权投资合伙企业（有限合伙）（以下简称"襄阳隆运"），具体详见公司于 2016 年 9 月 9 日和 2016 年 9 月 27 日在巨潮资讯网（www.cninfo.com.cn，下同） 披露的《关于投资设立产业基金暨关联交易的公告》《第八届董事会第十六次会 议决议公告》和《2016 年第四次临时股东大会决议公告》；公司分别于 2018 年 9 月 5 日和 2018 年 9 月 21 日召开的第九届董事会第十二次会议和 2018 年第九次 临时股东 ...

Core Viewpoint - Aoyuan Meigu Technology Co., Ltd. (stock abbreviation: *ST Meigu, stock code: 000615) has announced a resolution from its 27th meeting of the 11th Board of Directors, focusing on capital structure optimization and financial cost reduction through a capital reduction of approximately 108 million yuan for Xiangyang Longyun Equity Investment Partnership [1][3]. Group 1: Board Meeting Overview - The board meeting was held on November 5, 2025, with all 9 directors present, and the meeting procedures complied with relevant laws and regulations [2]. - All resolutions were passed unanimously with 9 votes in favor, 0 against, and 0 abstentions [2]. Group 2: Capital Reduction Details - The board approved a capital reduction of approximately 10.791 million yuan for Xiangyang Longyun, which represents 78.05% of the company's most recent audited net assets [3]. - The capital reduction will be proportionally distributed among partners based on their shareholding ratios, and the consolidation scope of the company will remain unchanged post-reduction [3]. Group 3: Shareholder Meeting Proposal - The board proposed to convene the 2025 third extraordinary general meeting of shareholders on November 25, 2025, to discuss the capital reduction and amendments to the company’s articles of association [4]. - The meeting will address two main topics: the approved capital reduction and the proposed amendments to the articles of association and governance systems [4]. - Aoyuan Meigu stated that these measures are crucial for strategic adjustments, enhancing capital efficiency and overall operational effectiveness [4].

Core Viewpoint - *ST Meigu's strategic adjustment aims to optimize capital structure, reduce overall financial costs, and enhance operational efficiency through a capital reduction of approximately 107.91 million yuan [1] Group 1 - The company plans to reduce capital for Xiangyang Longyun by about 107.91 million yuan, which accounts for approximately 78.05% of the latest audited net assets [1] - All partners will proportionally reduce their capital according to their shareholding ratios [1] - The completion of this capital reduction will not change the scope of the company's consolidated financial statements [1]

证券代码：000615 证券简称：*ST美谷 公告编号：2025-091 奥园美谷科技股份有限公司 关于召开 2025 年第三次临时股东会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、召开会议基本情况 1、股东会届次：2025 年第三次临时股东会。 2、股东会召集人：公司董事会。 3、会议召开的合法、合规性：本次股东会的召集程序符合有关法律、行政 法规、部门规章、规范性文件和《公司章程》的规定。 4、会议召开日期： （1）现场会议时间：2025 年 11 月 25 日（星期二）下午 15:30 开始； （2）网络投票时间：2025 年 11 月 25 日 通过深圳证券交易所交易系统进行网络投票的时间为：2025 年 11 月 25 日的 交易时间，即上午 9:15-9:25，9:30-11:30，下午 13:00-15:00； 通过深圳证券交易所互联网投票系统进行网络投票的时间为：2025 年 11 月 25 日上午 9:15 至下午 15:00 间的任意时间。 5、会议召开的方式： 本次股东会采用现场表决与网络投票相结合的方式召开： （1）于股 ...

本议案尚需提交公司股东会审议。 具体内容详见刊登在《证券时报》和巨潮资讯网（www.cninfo.com.cn）的 《关于对襄阳隆运减资的公告》。 表决结果：9 票同意，0 票反对，0 票弃权。 证券代码：000615 证券简称：*ST美谷 公告编号：2025-090 奥园美谷科技股份有限公司 第十一届董事会第二十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 奥园美谷科技股份有限公司（以下简称"公司"）第十一届董事会第二十七 次会议通知于 2025 年 11 月 3 日以电子通讯方式通知公司全体董事，会议于 2025 年 11 月 5 日下午以现场结合电子通讯方式召开。本次会议由董事长刘涛先生主 持，会议应到董事 9 人，实到董事 9 人。公司部分监事、高级管理人员列席了会 议。会议的召集、召开程序符合《中华人民共和国公司法》《公司章程》和《公 司董事会议事规则》的有关规定。经与会董事认真审议，通过了如下决议： 一、审议通过了《关于对襄阳隆运减资的议案》 基于公司发展战略调整，为优化公司资本结构，降低整体财务成本并提升经 营效益，董事会同意 ...

Group 1 - The core point of the article is that *ST Meigu (SZ 000615) held its 27th meeting of the 11th Board of Directors on November 5, 2025, to discuss the proposal for the third extraordinary shareholders' meeting in 2025 [1] - For the first half of 2025, *ST Meigu's revenue composition is as follows: medical beauty services accounted for 57.47%, bio-based fibers accounted for 38.54%, and others accounted for 3.99% [1] - As of the report date, *ST Meigu has a market capitalization of 3 billion yuan [1]

Group 1 - The medical beauty sector increased by 0.18% on November 6, with *ST Meigu leading the gains [1] - The Shanghai Composite Index closed at 4007.76, up 0.97%, while the Shenzhen Component Index closed at 13452.42, up 1.73% [1] - The trading volume and turnover for *ST Meigu were 137,900 hands and 53.13 million yuan, respectively, with a price increase of 3.95% [1] Group 2 - The medical beauty sector experienced a net outflow of 34.96 million yuan from main funds, while retail investors saw a net inflow of 36.62 million yuan [1] - Individual stock performances included *ST Meigu with a 3.95% increase, Aimeike with a 0.38% increase, Huaxi Biological with a 0.52% decrease, and Jinbo Biological with a 2.54% decrease [1] - The net fund flow for *ST Meigu was -3.52 million yuan, indicating a decrease of 6.63% [2]